REXULTI

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, Ecuador, Hong Kong SAR China, Israel, Japan, Singapore, South Africa, Turkey.

Active ingredients

The drug REXULTI contains one active pharmaceutical ingredient (API):

1	Brexpiprazole UNII 2J3YBM1K8C - BREXPIPRAZOLE
	Brexpiprazole is an atypical antipsychotic agent. The pharmacology of brexpiprazole is believed to be mediated by a modulatory activity at the serotonin and dopamine systems that combines partial agonist activity at serotonergic 5-HT1A and at dopaminergic D2 receptors with antagonist activity at serotonergic 5-HT2A receptors, with similar high affinities at all of these receptors.
	Read more about Brexpiprazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
REXULTI Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AX16		N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11184P, 11188W, 11189X, 11190Y
BR	Câmara de Regulação do Mercado de Medicamentos	524220080004407, 524220080004507, 524220080004607, 524220080004707, 524220080004807, 524220080004907
CA	Health Products and Food Branch	02461749, 02461757, 02461765, 02461773, 02461781, 02461803, 02485923
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	4813-MEE-0919, 4867-MEE-1119, 5014-MEE-0320, 5015-MEE-0320, 5191-MEE-0620, 5192-MEE-0620
HK	Department of Health Drug Office	66303, 66304, 66305, 66306, 66307, 66308
IL	מִשְׂרַד הַבְּרִיאוּת	8635, 8636, 8637, 8638, 9341
JP	医薬品医療機器総合機構	1179058F1020, 1179058F2027, 1179058F3023, 1179058F4020, 1179058F5026
SG	Health Sciences Authority	15763P, 15764P, 15765P, 15766P, 15767P, 15768P
TR	İlaç ve Tıbbi Cihaz Kurumu	8680683090028, 8680683090035, 8680683090042, 8680683090059, 8680683090066
US	FDA, National Drug Code	59148-035, 59148-036, 59148-037, 59148-038, 59148-039, 59148-040
ZA	Health Products Regulatory Authority	51/2.6.5/0502, 51/2.6.5/0503, 51/2.6.5/0504, 51/2.6.5/0505